Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Total Revenue of $1.01 million for fiscal year 2025.
60 DEGREES PHARMACEUTICALS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.01M | +65.5% |
| 2024 | $607.6K | +139.6% |
| 2023 | $253.6K | +13.6% |
| 2022 | $223.2K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $437.6K | +223.4% | +333.6% |
| June 30, 2025 | $100.9K | -19.2% | -38.3% |
| March 31, 2025 | $163.6K | +54.8% | +20.9% |
| September 30, 2024 | $135.3K | +164.3% | +8.3% |
| June 30, 2024 | $125.0K | +109.9% | +18.3% |
| March 31, 2024 | $105.7K | +515.4% | +106.4% |
| September 30, 2023 | $51.2K | -69.6% | -14.0% |
| June 30, 2023 | $59.5K | +31.8% | +246.7% |
- 60 DEGREES PHARMACEUTICALS, INC. showed an increase of +65.5% in Total Revenue compared to the prior fiscal year.
- Over the 2022–2025 period, 60 DEGREES PHARMACEUTICALS, INC.’s total revenue has grown by 350.5% (from $223.2 thousand to $1.01 million).
- The most recent figure is from 60 DEGREES PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: